APA
Tarantelli C., Bernasconi E., Gaudio E., Cascione L., Restelli V., Arribas A. J., Spriano F., Rinaldi A., Mensah A. A., Kwee I., Ponzoni M., Zucca E., Carrassa L., Riveiro M. E., Rezai K., Stathis A., Cvitkovic E. & Bertoni F. (2018). BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance. : ESMO open.
Chicago
Tarantelli Chiara, Bernasconi Elena, Gaudio Eugenio, Cascione Luciano, Restelli Valentina, Arribas Alberto Jesus, Spriano Filippo, Rinaldi Andrea, Mensah Afua Adjeiwaa, Kwee Ivo, Ponzoni Maurilio, Zucca Emanuele, Carrassa Laura, Riveiro Maria E, Rezai Keyvan, Stathis Anastasios, Cvitkovic Esteban and Bertoni Francesco. 2018. BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance. : ESMO open.
Harvard
Tarantelli C., Bernasconi E., Gaudio E., Cascione L., Restelli V., Arribas A. J., Spriano F., Rinaldi A., Mensah A. A., Kwee I., Ponzoni M., Zucca E., Carrassa L., Riveiro M. E., Rezai K., Stathis A., Cvitkovic E. and Bertoni F. (2018). BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance. : ESMO open.
MLA
Tarantelli Chiara, Bernasconi Elena, Gaudio Eugenio, Cascione Luciano, Restelli Valentina, Arribas Alberto Jesus, Spriano Filippo, Rinaldi Andrea, Mensah Afua Adjeiwaa, Kwee Ivo, Ponzoni Maurilio, Zucca Emanuele, Carrassa Laura, Riveiro Maria E, Rezai Keyvan, Stathis Anastasios, Cvitkovic Esteban and Bertoni Francesco. BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance. : ESMO open. 2018.